royalty revenue from Europe has increased from $255,000 to $400,000 and royalty revenue from the US has increased from $20,000 to $36,000. i recognize that the increases are off a low base, but very happy that's its going in the right direction. hoping FDA approves any 1 of the 3 dossiers(currently submitted to them for evaluation , Jublia - Elma and Testerone generics) soon. Once 1 is approved ACR will have proved its current strategy works and will start gathering momentum
Add to My Watchlist
What is My Watchlist?
